Annals ofRheumatology

Volume: 4 - Number: 31 - April 15, 2004
Archive of Annals of Rheumatology

In this issue

Seguimos creciendo para Brindar el mejor servicio

Editorial

Neuroendocrine Immune Perturbations in Rheumatoid Arthritis: Causes, Consequences, or Confounders in the Disease Process?

New Insights into Prostaglandin Biology

Not Yet Time to Change the Guidelines for Monitoring Methotrexate Liver Toxicity: They Have Served Us Well

Novel Concepts of Severity Mechanisms in Ankylosing Spondylitis

OA and BMD: What Is the Relation and Why Does It Matter?

Occupational Low Back Pain

OMERACT 6 Brings New Perspectives to Rheumatology Measurement Research

Opioid Therapy for Osteoarthritis of the Hip and Knee: Use It or Lose It?

Options in Disability Determination. Lessons That Pertain to the Regional Musculoskeletal Disorders

Osteoarthritis: Simple Analgesics versus NSAID

Osteoprotegerin, RANK, and RANK Ligand: The Good, the Bad, and the Ugly in Rheumatoid Arthritis

Pain Is Real; Fibromyalgia Isn't

Pain Relief in Osteoarthritis: The Rationale for Combination Therapy

Patient Self-Management in Arthritis? Yes!

Patient Self-Management in Arthritis? Yes, More Research!

Pharmacogenetics for the Individualization of Treatment of Rheumatic Disorders Using Azathioprine

PPARg Ligands as Modulators of Inflammatory and Catabolic Responses in Arthritis. An Overview

Primary Angiitis of the Central Nervous System: the Penumbra of Vasculitis

Profits, Pressure, and Perception: Expensive Research Collides with Medicine

Pros and Cons of Selective Inhibition of Cyclooxygenase-2 versus Dual Lipoxygenase/Cyclooxygenase Inhibition: Is Two Better than One?

Psychosocial Factors in Diffuse Upper Limb Disorder

Results from Controlled Clinical Trials: How Relevant for Clinical Practice?

Retinoids and Rexinoids for the 21st Century: A Brave New World for Arthritis

Rheumatic Disease in Han Chinese. What Have We Learned from 19 Years of Epidemiological Study

Seguimos creciendo para Brindar el mejor servicio

Pharmacology

NSAID Toxicity: Where Are We and How Do We Go Forward?

Buscador

Copyright © Dr. Mario I. Cámera .:. Powered by ForamenAlojado en ...